A jury in Philadelphia ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who says the drug Risperdal caused him to grow breast tissue. The lawsuit claimed the drugmaker downplayed the risk of breast tissue growth in boys.Oct. 9, 2019
